Venture Capital

Updated:

Linc (Sweden)

Linc is a Stockholm-based venture capital firm that invests in Nordic life science companies. The firm's investment strategy focuses on two main areas within...

Linc (Sweden)

Linc is a Stockholm-based venture capital firm that invests in Nordic life science companies. The firm's investment strategy focuses on two main areas within life sciences: early-phase pharmaceuticals and mature medical technology firms. Linc targets companies operating in the Nordic region, concentrating its capital and expertise on the life science sector. As a venture capital investor headquartered in Sweden, Linc seeks opportunities across the pharmaceutical development pipeline at early stages as well as established medical technology businesses. The firm's sector focus is exclusively life sciences, with a stage approach that spans early-stage drug development and later-stage medtech.

General information

Firm type

Venture Capital

Location

Country

Sweden

City

Stockholm

Corporate office

Stockholm, Sweden

Sector focus

Venture CapitalSweden

Frequently asked questions

What is Linc's investment focus?

Linc invests in Nordic life science companies, with a focus on early-phase pharmaceuticals and mature medical technology firms.

Where is Linc headquartered?

Linc is headquartered in Stockholm, Sweden.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on venture capital firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Stockholm Venture Capital profiles